Impact on quality of life and safety of sublingual and subcutaneous immunotherapy in children with severe house dust mite and pollen-associated allergic rhinoconjunctivitis

Impact on quality of life and safety of sublingual and subcutaneous immunotherapy in children with severe house dust mite and pollen-associated allergic rhinoconjunctivitis

Abstract Background Pollen and house dust mite (HDM) subcutaneous immunotherapy (SLIT) and pollen subcutaneous immunotherapy (SCIT) are effective therapies for children with allergic rhinoconjunctivitis (AR). There are no previous direct comparative studies investigating quality of life (QoL) of all...

Full description

Bibliographic Details
Main Authors: Thomas Proctor, Elodie Morrough, Otto Fenske, Sarah Allatt, Stephen M. Hughes, Vibha Sharma, Peter D. Arkwright
Format: Article
Language:English
Published: Wiley 2020-04-01
Series:Clinical and Translational Allergy
Subjects:
Children
Allergic rhinoconjunctivitis
Immunotherapy
Sublingual
Subcutaneous
Pollen
Online Access:http://link.springer.com/article/10.1186/s13601-020-00315-0

Internet

http://link.springer.com/article/10.1186/s13601-020-00315-0

Similar Items